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Abstract
Background: Galactosamine (GalN), an established experimental toxin, mainly causes liver injury
via the generation of free radicals and depletion of UTP nucleotides. Renal failure is often associated
with end stage liver damage. GalN intoxication also induces renal dysfunction in connection with
hepatic disorders. Present study was designed to find out the effect of a protein isolated from the
leaves of the herb Cajanus indicus against GalN induced renal damage.
Methods: Both preventive as well as curative effect of the protein was investigated in the study.
GalN was administered intraperitoneally at a dose of 800 mg/kg body weight for 3 days pre and
post to protein treatment at an intraperitoneal dose of 2 mg/kg body weight for 4 days. The
activities of antioxidant enzymes, superoxide dismutase (SOD), catalase (CAT), glutathione
reductase (GR) and glutathione-S-transferase (GST), levels of cellular metabolites, reduced
glutathione (GSH), total thiols, oxidized glutathione (GSSG) and lipid peroxidation end products
were determined to estimate the status of the antioxidative defense system. In addition, serum
creatinine and urea nitrogen (UN) levels were also measured as a marker of nephrotoxicity.
Results: Results showed that GalN treatment significantly increased the serum creatinine and UN
levels compared to the normal group of mice. The extent of lipid peroxidation and the level of
GSSG were also enhanced by the GalN intoxication whereas the activities of antioxidant enzymes
SOD, CAT, GR and GST as well as the levels of total thiols and GSH were decreased in the kidney
tissue homogenates. Protein treatment both prior and post to the toxin administration successfully
altered the effects in the experimental mice.
Conclusion: Our study revealed that GalN caused a severe oxidative insult in the kidney. Protein
treatment both pre and post to the GalN intoxication could protect the kidney tissue against GalN
induced oxidative stress. As GalN induced severe hepatotoxicity followed by renal failure, the
protective role of the protein against GalN induced renal damages is likely to be an indirect effect.
Since the protein possess hepatoprotective activity, it may first ameliorate GalN-induced liver
damage and consequently the renal disorders are reduced. To the best of our knowledge, this is
probably the first report describing GalN-induced oxidative stress in renal damages and the
protective role of a plant protein molecule against it.
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Background
Galactosamine (GalN) is a well known toxin and has been
found to possess various adverse effects in liver. Its toxic
effect is associated with the depletion of UTP nucleotides
followed by the formation of UDP hexosamines [1] and
leads to the inhibition of transcription and consequently
the translation processes [2]. The development of acute
liver failure due to the administration of GalN is well doc-
umented [3-5]. Javle et al reported that GalN-induced
liver injury is associated with the development of renal
failure [6]. Recently, the term hepatorenal syndrome
(HRS) has been introduced to define the development of
renal failure in the absence of clinical, anatomical or path-
ological causes of that failure. Classically, HRS is associ-
ated with the end-stage liver cirrhosis and it has been
observed that renal failure occurs with this liver disease in
about 50% of patients [7]. A very recent report of Anand
et al revealed that renal failure appeared with acute liver
damage where the histological status of the kidney was
normal but the renal blood flow was decreased [8].
Although oxidative stress has been reported as one of the
major causes in GalN induced liver damages [9-11], it is
not, however, clear whether GalN-induced renal disorders
occur via the generation of reactive oxygen species fol-
lowed by oxidative stress in the kidney or not.
Herbal medicines have been used traditionally world
wide for the prevention and treatment of various diseases.
Earlier studies reported that medicinal herbs play a protec-
tive role against GalN induced liver damage [12-14]. In
India medicinal plants are widely used in the ayurvedic
medicines for the treatment of various health problems.
Some of the important medicinal plants are Silybum mari-
anum [15,16]; Picrorhiza kurroa [17]; Curcuma longa [18];
Phyllanthus niruri [19-23];  Terminalia arjuna [24-26];
Andrographis paniculata [27] etc. The herb Cajanus indicus,
an important medicinal plant, has been widely used in
folklore medicine in India and many other countries for
the treatment of various hepatic disorders [28,29]. In our
laboratory a 43 kD protein has been isolated and purified
to homogeneity from the leaves of this herb [30] and
believed to be an active principle responsible for its bene-
ficial action. It has been found that that the protein pos-
sesses a protective role against various toxins (such as
carbon tetrachloride, chloroform, thioaectamide etc.)
induced hepatic disorders [31-34]. The free radical scav-
enging activity of this protein was determined from its
DPPH radical quenching ability [31]. The present study
was conducted to find out whether GalN caused renal
damage by inducing oxidative stress in the kidney and
whether the protein of our interest could ameliorate that
effect. Experiments were designed accordingly to evaluate
both the preventive as well as curative role of this protein
against GalN induced renal toxicity in vivo. The extent of
renal damage caused by GalN intoxication and the protec-
tive effect of the protein were evaluated by measuring the
i) level of serum creatinine and urea nitrogen (UN) ii)
activities of the intracellular enzymes namely, superoxide
dismutase (SOD), catalase (CAT), glutathione reductase
(GR) and glutathione-S-transferase (GST) iii) levels of cel-
lular metabolites like reduced glutathione (GSH), total
thiols, oxidized glutathione (GSSG) and iv) extent of lipid
peroxidation in the kidney tissue homogenates of all the
experimental animals.
Methods
Plant
Cajanus indicus is a shrub belonging to the family Legumi-
nosae and subfamily papilionacea. Fresh young leaves
were collected from Bose Institute experimental farm.
Animals
Swiss albino mice (male, body weight 20 ± 2 g) were used
for the experiments. The animals were acclimatized under
standard laboratory conditions for a fortnight before start-
ing the experiments. They were provided with standard
diet and water ad libitum. They were maintained under
standard conditions of temperature (30°C) and humidity
(50%) with an alternating 12 hours light/dark cycles. All
the experimental studies were conducted in conformity
with the guidance for care and standard experimental ani-
mals study ethical protocols. The animals were divided
into several groups, each group having six mice.
Chemicals
Bovine serum albumin (BSA) and Bradford reagent were
purchased from Sigma-Aldrich Chemical Company, (St.
Louis, MO) USA. Kit for determination of creatinine and
UN were purchased from Span Diagnostic Ltd. Ammo-
nium sulphate [(NH4)2SO4], 1- chloro-2,4-dinitroben-
zene (CDNB), D(+)-galactosamine hydrochloride
(GalN), 5,5'-dithiobis(2-nitrobenzoic acid) [DTNB, (Ell-
man's reagent)], ethylene diamine tetraacetic acid
(EDTA), N-ethylmaleimide (NEM), nicotinamide ade-
nine dinucleotide reduced (NADH), nitro blue tetrazo-
lium (NBT), oxidized glutathione (GSSG), phenazine
methosulphate (PMT), potassium dihydrogen phosphate
(KH2PO4), reduced glutathione (GSH), sodium pyro-
phosphate, trichloro acetic acid (TCA), thiobarbituric acid
(TBA), vitamin E were bought from Sisco Research Labo-
ratory, India.
Preparation of the homogeneous protein from the leaves 
of Cajanus indicus
The protein was purified from the leaves of Cajanus indicus
according to the method described by Sarkar et al [30].
The leaves were homogenized in 20 mM tris-HCl buffer,
pH 7.4 and the supernatant was brought to 60%
(NH4)2SO4 saturation. The pellet was reconstituted and
dialyzed in tris-HCl buffer, passed through DEAE Sepha-BMC Complementary and Alternative Medicine 2007, 7:11 http://www.biomedcentral.com/1472-6882/7/11
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dex column and eluted in linear gradient of 0–1 M NaCl
in tris buffer. The active fraction eluted at 0.2 M NaCl was
concentrated and applied on a Sephadex G-50 column.
The bioactive fraction obtained was subjected to a C18
hydrophobic column for reverse phase column chroma-
tography. The homogeneity of preparation was deter-
mined by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE).
Protein estimation
The protein concentration of the experimental samples
was measured according to the method of Bradford [35]
using crystalline BSA as standard.
Pre treatment with the protein
The pre-treatment group was divided into five sub-groups
each consisted of six mice. The first group, which received
only the vehicle, served as normal control. The second
group, served as toxin control, in which GalN was admin-
istered intraperitoneally at a dose of 800 mg/kg body
weight once daily and the treatment was carried out for 3
days. The third group of mice was pre-treated with the
protein by intraperitoneal injection at a dose of 2 mg/kg
body weight once daily and the treatment was carried out
for 4 days followed by the toxin treatment for another 3
days. The animals were then sacrificed under anesthesia
and kidneys were collected. A well-known antioxidant
agent vitamin E, (at a dose of 200 mg/kg body weight)
and a non-relevant protein, BSA (at a dose of 2 mg/kg
body weight) were used as the positive and negative con-
trols respectively for the study.
Post-treatment with the protein
The post-treatment group was divided into five sub-
groups each consisted of six mice. The first group, served
as normal control, received only the vehicle. The second
group received GalN at a dose of 800 mg/kg body weight
intraperitoneally (once daily) for 3 days and served as the
toxin control. The third group of mice was intoxicated
with GalN (800 mg/kg body weight, once daily) for 3 days
followed by intraperitoneal administration of the protein
at a dose of 2 mg/kg body weight once daily for 4 days.
The fourth group received GalN (800 mg/kg body weight,
once daily) for 3 days and then kept for another 4 days
without any treatment to observe whether there is any nat-
ural recovery or not. A positive control group was kept in
which mice were treated with 200 mg/kg body weight
vitamin E for 4 days after GalN intoxication. Mice were
then sacrificed under anesthesia and kidneys were col-
lected.
Preparation of kidney homogenates
The kidney tissues were homogenized using glass homog-
enizer in 100 mM potassium phosphate buffer containing
1 mM EDTA, pH 7.4 and centrifuged at 12,000 g for 30
minutes at 4°C. The supernatant was collected and used
for following experiments.
Assessment of marker of nephrotoxicity
Estimation of creatinine level
Blood samples collected from puncturing mice hearts
were kept overnight at 4°C to clot and then centrifuged at
3,000 g for 10 minutes. Creatinine level was measured
from serum samples according to the method of Bonses
and Taussky [36].
Estimation of UN level
Estimation of UN level has been carried following the
method of Crocker [37]. Like creatine measurement,
blood samples were collected from puncturing mice
hearts and kept overnight at 4°C to clot. Sera from the
samples were collected by centrifuging the blood samples
at 3,000 g for 10 minutes. UN level in all the experimental
samples were measured by using a kit from Span Diagnos-
tics Limited, India.
Estimation of lipid peroxidation end products
The extent of lipid peroxidation in terms of thiobarbituric
acid reactive substances (TBARS) formation was measured
according to the method of Esterbauer and Cheeseman
[38] using the extinction co-efficient of MDA, which is
1.56 × 105 M-1cm-1.
Assay of antioxidant enzymes
SOD assay
The activity of SOD was measured following the method
originally developed by Nishikimi [39] and then modi-
fied by Kakkar [40]. One unit of SOD activity is defined,
as the enzyme concentration required inhibiting chro-
mogen production by 50% in one minute under the assay
condition.
CAT assay
The enzyme CAT converts H2O2 into water. The CAT activ-
ity was measured by the method of Bonaventura [41].
One unit of CAT activity is defined as the amount of
enzyme, which reduces 1 µmol of H2O2 per minute.
GST assay
GST catalyzes the conjugation reaction with glutathione
in the first step of mercapturic acid synthesis. The activity
of GST was measured by the method of Habig and Jakoby
[42]. One unit of GST activity is 1 µmol product forma-
tion per minute.
Assay of GR
GR activity was measured according to the method of
Smith [43]. The enzyme activity was calculated using
molar extinction coefficient of 13,600 M-1cm-1. One unit
of enzyme activity is defined as the amount of enzyme,BMC Complementary and Alternative Medicine 2007, 7:11 http://www.biomedcentral.com/1472-6882/7/11
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which catalyzes the oxidation of 1µmol NADPH per
minute.
Assay of cellular metabolites from kidney homogenates
GSH assay
GSH level was measured according to the method of Ell-
man [44]. A standard curve was drawn using different
known concentrations of GSH solution. With the help of
this standard curve, GSH contents were calculated.
GSSG assay
GSSG level was measured according to the method of His-
sin and Hilf [45]. The absorbance of the sample was meas-
ured at 412 nm.
Assay of total thiols
The total thiols (total sulfhydryl groups) content was
measured according to the method of Sedlak and Lindsay
[46] with some modifications. The content of total thiols
was calculated using molar extinction coefficient of
13,600 M-1cm-1.
Statistical analysis
All the values are represented as mean ± S.D. (n = 6). The
statistical differences among different groups were anal-
ised by Student's t-test. P values of 0.05 or less were con-
sidered significant.
Results
Effect on nephrotoxicity markers
Creatinine levels
The creatinine levels in serum obtained from the normal
control mice, toxin control mice, mice treated separately
with protein, vitamin E and BSA followed by GalN intox-
ication, mice treated separately with protein, vitamin E
after GalN intoxication and mice kept for normal recovery
after GalN administration are shown in figure 1. The cre-
atinine level was elevated in toxin control (0.85 ± 0.038
mg/dl) compared to the normal control (0.66 ± 0.026
mg/dl), whereas protein pre-treatment reduced the level
(0.68 ± 0.029 mg/dl). There was reduction of creatinine
level (0.65 ± 0.033 mg/dl) in protein post- treated group
of mice. The normal recovery after toxin administration
was very slow (0.79 ± 0.036 mg/dl).
UN levels
Figure 2 represents UN level in serum of all the experi-
mental animals. In toxin control an increase in UN level
(44.68 ± 1.98 mg/dl) has been observed compared to the
normal control (26.57 ± 1.22 mg/dl), whereas protein
pre-treatment attenuated the level (30.71 ± 1.39 mg/dl).
Protein post treatment also reduced the UN level (27.47 ±
1.29 mg/dl). The normal recovery after toxin administra-
tion was not significant (40.62 ± 1.78 mg/dl).
Effect on the end products of lipid peroxidation
Figure 3 shows the levels of MDA in kidney tissue
homogenates obtained from all the experimental mice.
MDA level (41.22 ± 0.92 nmol/g tissue) in kidney tissue
homogenates of GalN treated mice was found to be higher
than that level compared to normal control mice (27.99 ±
0.59 nmol/g tissue). Pre-treatment with the protein fol-
lowed by toxin administration decreased the level (15.35
± 0.45 nmol/g tissue). Post treatment with the protein
after toxin administration decreased MDA level (10.17 ±
0.52 nmol/g tissue) also. The normal recovery after toxin
treatment was very slow (40.91 ± 0.82 nmol/g tissue).
Effect on antioxidant enzymes
SOD activities
SOD activities in kidney tissue homogenates of all experi-
mental mice are shown in figure 4. SOD activity was
reduced in toxin control mice (19.21 ± 0.85 unit/mg pro-
tein) compared to the normal control (80.55 ± 1.61 unit/
mg protein). There was increase in SOD activity in the
protein treated mice (85.65 ± 1.71 unit/mg protein) prior
to GalN administration and in protein treated mice
(99.82 ± 2.09 unit/mg protein) after GalN administration.
No significant normal recovery (30.25 ± 0.83 unit/mg
protein) after toxin treatment was observed.
CAT activities
CAT activities in kidney tissue homogenates of all experi-
mental mice are shown in figure 5. There was decreased
CAT activity in toxin control (176.96 ± 3.89 µmol/min/
mg protein) compared to the normal control (348.31 ±
6.62 µmol/min/mg protein). Pre as well as post-treatment
with the protein increased CAT activity. The activities were
336.06 ± 7.22 µmol/min/mg protein and 344.49 ± 7.41
µmol/min/mg protein respectively. The normal recovery
after toxin treatment was not significant (192.95 ± 4.51
µmol/min/mg protein).
GST activities
GST activities in kidney tissue homogenates of all experi-
mental mice are shown in figure 6. A decreased GST activ-
ity was observed in toxin control (1.16 ± 0.03 µmol/min/
mg protein) compared to the normal control (3.01 ± 0.08
µmol/min/mg protein). Protein treatment prior to GalN
intoxication caused an elevation in GST activity (3.35 ±
0.09 µmol/min/mg protein). GST activity (2.78 ± 0.04
µmol/min/mg protein) was also elevated in mice group
treated with protein after toxin administration. The nor-
mal recovery after toxin treatment was very slow (1.48 ±
0.03 µmol/min/mg protein).
GR activities
GR activities in kidney tissue homogenates obtained from
all the experimental mice are shown in figure 7. There was
reduction of GR activity in toxin control (142.18 ± 2.74BMC Complementary and Alternative Medicine 2007, 7:11 http://www.biomedcentral.com/1472-6882/7/11
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Effect of the protein on creatinine level in GalN induced kidney damage in mice Figure 1
Effect of the protein on creatinine level in GalN induced kidney damage in mice. Left and right panel show preventive and cur-
ative effect of the protein respectively. Cont: creatinine level in normal mice, GalN: creatinine level in only GalN treated mice, 
Protein + GalN: creatinine level in which the protein was given prior to GalN administration, VitE + GalN: creatinine level in 
which vitamin E was administered prior to GalN treatment, BSA + GalN: creatinine level in which BSA was given before GalN 
administration. GalN + Protein: creatinine level in which the protein was given after GalN administration, GalN + Vit E: creat-
inine level in which vitamin E was administered post to GalN treatment and Recovery: creatinine level in mice which were 
treated with GalN for 3 days and kept next 4 days without any treatment. Each column represents mean ± SD, n = 6. "a" indi-
cates the significant difference between the vehicle control and toxin treated groups, "b" indicates the significant difference 
between the toxin treated and protein treated groups and "c" indicates the significant difference between the toxin treated and 
vitamin E treated groups. (Pa < 0.01, Pb < 0.01, Pc < 0.01).
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Effect of the protein on UN level in GalN induced kidney damage in mice Figure 2
Effect of the protein on UN level in GalN induced kidney damage in mice. Left and right panel show preventive and curative 
effect of the protein respectively. Cont: UN level in normal mice, GalN: UN level in only GalN treated mice, Protein + GalN: 
UN level in which the protein was given prior to GalN administration, VitE + GalN: UN level in which vitamin E was adminis-
tered prior to GalN treatment, BSA + GalN: UN level in which BSA was given before GalN administration. GalN + Protein: 
UN level in which the protein was given after GalN administration, GalN + Vit E: UN level in which vitamin E was administered 
post to GalN treatment and Recovery: UN level in mice which were treated with GalN for 3 days and kept next 4 days with-
out any treatment. Each column represents mean ± SD, n = 6. "a" indicates the significant difference between the vehicle con-
trol and toxin treated groups, "b" indicates the significant difference between the toxin treated and protein treated groups and 
"c" indicates the significant difference between the toxin treated and vitamin E treated groups. (Pa < 0.01, Pb < 0.01, Pc < 0.01).
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Effect of the protein on TBARS formation in GalN induced kidney damage in mice Figure 3
Effect of the protein on TBARS formation in GalN induced kidney damage in mice. Left and right panel show preventive and 
curative effect of the protein respectively. Cont: MDA content in normal mice, GalN: MDA content in only GalN treated mice, 
Protein + GalN: MDA level in which the protein was given prior to GalN administration, VitE + GalN: MDA level in which vita-
min E was administered prior to GalN treatment, BSA + GalN: MDA level in which BSA was given before GalN administration. 
GalN + Protein: MDA content in which the protein was given after GalN administration, GalN + Vit E: MDA level in which 
vitamin E was administered post to GalN treatment and Recovery: MDA content in mice which were treated with GalN for 3 
days and kept next 4 days without any treatment. Each column represents mean ± SD, n = 6. "a" indicates the significant differ-
ence between the vehicle control and toxin treated groups, "b" indicates the significant difference between the toxin treated 
and protein treated groups and "c" indicates the significant difference between the toxin treated and vitamin E treated groups. 
(Pa < 0.01, Pb < 0.01, Pc < 0.01).
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Effect of the protein on SOD activity in GalN induced kidney damage in mice Figure 4
Effect of the protein on SOD activity in GalN induced kidney damage in mice. Left and right panel show preventive and curative 
effect of the protein respectively. Cont: SOD activity in normal mice, GalN: SOD activity in only GalN treated mice, Protein + 
GalN: SOD activity in which the protein was given prior to GalN administration, VitE + GalN: SOD activity in which vitamin E 
was administered prior to GalN treatment, BSA + GalN: SOD activity in which BSA was given before GalN administration. 
GalN + Protein: SOD activity in which the protein was given after GalN administration, GalN + Vit E: SOD activity in which 
vitamin E was administered post to GalN treatment and Recovery: SOD activity in mice which were treated with GalN for 3 
days and kept next 4 days without any treatment. Each column represents mean ± SD, n = 6. "a" indicates the significant differ-
ence between the vehicle control and toxin treated groups, "b" indicates the significant difference between the toxin treated 
and protein treated groups and "c" indicates the significant difference between the toxin treated and vitamin E treated groups. 
(Pa < 0.01, Pb < 0.01, Pc < 0.01).
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Effect of the protein on CAT activity in GalN induced kidney damage in mice Figure 5
Effect of the protein on CAT activity in GalN induced kidney damage in mice. Left and right panel show preventive and curative 
effect of the protein respectively. Cont: CAT activity in normal mice, GalN: CAT activity in only GalN treated mice, Protein + 
GalN: CAT activity in which the protein was given prior to GalN administration, VitE + GalN: CAT activity in which vitamin E 
was administered prior to GalN treatment, BSA + GalN: CAT activity in which BSA was given before GalN administration. 
GalN + Protein: CAT activity in which the protein was given after GalN administration, GalN + Vit E: CAT activity in which 
vitamin E was administered post to GalN treatment and Recovery: CAT activity in mice which were treated with GalN for 3 
days and kept next 4 days without any treatment. Each column represents mean ± SD, n = 6. "a" indicates the significant differ-
ence between the vehicle control and toxin treated groups, "b" indicates the significant difference between the toxin treated 
and protein treated groups and "c" indicates the significant difference between the toxin treated and vitamin E treated groups. 
(Pa < 0.01, Pb < 0.01, Pc < 0.01).
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Effect of the protein on GST activity in GalN induced kidney damage in mice Figure 6
Effect of the protein on GST activity in GalN induced kidney damage in mice. Left and right panel show preventive and curative 
effect of the protein respectively. Cont: GST activity in normal mice, GalN: GST activity in only GalN treated mice, Protein + 
GalN: GST activity in which the protein was given prior to GalN administration, VitE + GalN: GST activity in which vitamin E 
was administered prior to GalN treatment, BSA + GalN: GST activity in which BSA was given before GalN administration. 
GalN + Protein: GST activity in which the protein was given after GalN administration, GalN + Vit E: GST activity in which 
vitamin E was administered post to GalN treatment and Recovery: GST activity in mice which were treated with GalN for 3 
days and kept next 4 days without any treatment. Each column represents mean ± SD, n = 6. "a" indicates the significant differ-
ence between the vehicle control and toxin treated groups, "b" indicates the significant difference between the toxin treated 
and protein treated groups and "c" indicates the significant difference between the toxin treated and vitamin E treated groups. 
(Pa < 0.01, Pb < 0.01, Pc < 0.01).
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nmol/min/mg protein) compared to the normal control
(293.38 ± 6.78 nmol/min/mg protein). Elevation of GR
activity (340.12 ± 8.33 nmol/min/mg protein) was
observed in protein pre-treatment group. Post treatment
with the protein increased GR activity (303.82 ± 7.17
nmol/min/mg protein) also. A little normal recovery
(166.72 ± 4.05 nmol/min/mg protein) after toxin treat-
ment was observed.
Effect on cellular metabolites
GSH levels
Figure 8 shows the levels of GSH in kidney tissue homoge-
nates obtained from all the experimental mice. There was
decrease of GSH level in toxin control (33.77 ± 1.52
nmol/mg protein) compared to that of normal control
(48.41 ± 2.28 nmol/mg protein), whereas protein pre-
treatment increased the level (50.44 ± 2.32 nmol/mg pro-
tein). An increased GSH level (51.23 ± 2.43 nmol/mg pro-
tein) was observed in kidney homogenates obtained from
the mice treated with the protein after toxin administra-
tion. There was no significant normal recovery (37.01 ±
1.77 nmol/mg protein) after toxin treatment.
GSSG levels
The levels of GSSG in kidney tissue homogenates
obtained from all the experimental mice are shown in fig-
ure 9. GSSG level in toxin control (2.24 ± 0.098 nmol/mg
protein) was found to be higher than that level compared
to normal control (1.14 ± 0.051 nmol/mg protein). Pre-
treatment with the protein followed by toxin administra-
tion decreased the level (1.11 ± 0.049 nmol/mg protein).
GSSG level (1.09 ± 0.052 nmol/mg protein) has been
found to decrease in post-treatment group of mice. The
normal recovery after toxin treatment was very slow (2.01
± 0.095 nmol/mg protein).
Levels of total thiols
Figure 10 shows the levels of total thiols in kidney tissue
homogenates obtained from all the experimental mice
groups. Toxin treatment decreased the level of total thiols
(253.28 ± 5.32 nmol/mg protein) compared to the nor-
mal control group (541.25 ± 10.83 nmol/mg protein)
whereas protein pre-treatment increased the level (440.83
± 11.25 nmol/mg protein). Post treatment of the protein
after GalN intoxication increased the level of total thiols
(433.73 ± 10.11 nmol/mg protein) compared to toxin
control group. No significant normal recovery (264.88 ±
5.29 nmol/mg protein) after toxin treatment was found.
Vitamin E treatment pre and post to GalN intoxication
could protect kidney by preventing alterations in all the
antioxidant indices described in the present study,
whereas BSA did not show any protective activity.
Discussion
The aim of the present study was to investigate whether
the protein isolated from the herb Cajanus indicus pos-
sesses any preventive as well as curative role against GalN
induced renal damages. Results suggest that administra-
tion of GalN at a dose of 800 mg/kg body weight for 3
days significantly altered the status of the antioxidant
defense system in the kidney. Protein treatment both pre
and post to the toxin administration restored the activities
of all the intracellular antioxidant enzymes as well as level
of cellular metabolites.
Reports on the mechanism of GalN induced hepatotoxic-
ity suggests that GalN inhibits the synthesis of RNA as well
as protein via reduction of cellular UTP, a substrate for
RNA polymerase. GalN shifts the equilibrium between the
uridine phosphate consuming and producing reactions,
in favor of the former via the rapid formation and accu-
mulation of UDP amino sugars [2]. Studies from Quin-
tero et al [47] showed that free radical dependent pathway
is involved in GalN induced hepatic apoptosis and necro-
sis in rat hepatocytes. Mangeney-Andreani et al [10] sug-
gested that energy metabolism of hepatocytes was also
inhibited by GalN application. In addition, report from
Sire et al [48] reveals that GalN damaged the enzymes
involved in the transport of substrates to the mitochon-
dria and consequently modified the phospholipid com-
position of the membrane. It has been observed that
patient suffering with liver disease have a decrease in renal
blood flow, indicating renal vasoconstriction and this
effect is more prominent in those people affected with
HRS [49]. Earlier studies reported that endothelin-1 (ET-
1), one of the most potent vasoconstrictor in biological
system, induces renal vasoconstriction as well as reduc-
tion in glomerular filtration rate (GFR), renal blood flow
and sodium excretion [50]. Uchida et al [51] and
Sakamoto et al [52] reported that various cells within the
kidney tissue either express mRNA for ET-1 or can synthe-
sis ET-1 and thus it reveals that ET-1 may, therefore, have
a paracrine or autocrine effect. It has been observed that
the levels of plasma ET-1 concentration are elevated in
patients with severe liver disease and HRS [53]. Annand et
al [8] reported that GalN intoxication causes liver injury
followed by renal impairment, which is manifested by the
decrease in renal blood flow, creatinine clearance as well
as increase in plasma ET-1 concentration and also up-reg-
ulation of ET-1 receptor in renal cortex although kidneys
are histologically normal. Thus study also suggests that
renal failure also appears to be secondary to liver failure.
In the present study we found that GalN administration at
a dose of 800 mg/kg body weight for three days caused
enhanced oxidative insult in the kidney tissue as evi-
denced by the increased renal TBARS level and depletion
in the activities of endogenous antioxidant enzymes suchBMC Complementary and Alternative Medicine 2007, 7:11 http://www.biomedcentral.com/1472-6882/7/11
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Effect of the protein on GR activity in GalN induced kidney damage in mice Figure 7
Effect of the protein on GR activity in GalN induced kidney damage in mice. Left and right panel show preventive and curative 
effect of the protein respectively. Cont: GR activity in normal mice, GalN: GR activity in only GalN treated mice, Protein + 
GalN: GR activity in which the protein was given prior to GalN administration, VitE + GalN: GR activity in which vitamin E was 
administered prior to GalN treatment, BSA + GalN: GR activity in which BSA was given before GalN administration. GalN + 
Protein: GR activity in which the protein was given after GalN administration, GalN + Vit E: GR activity in which vitamin E was 
administered post to GalN treatment and Recovery: GR activity in mice which were treated with GalN for 3 days and kept 
next 4 days without any treatment. Each column represents mean ± SD, n = 6. "a" indicates the significant difference between 
the vehicle control and toxin treated groups, "b" indicates the significant difference between the toxin treated and protein 
treated groups and "c" indicates the significant difference between the toxin treated and vitamin E treated groups. (Pa < 0.01, Pb 
< 0.01, Pc < 0.01).
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Effect of the protein on GSH level in GalN induced kidney damage in mice Figure 8
Effect of the protein on GSH level in GalN induced kidney damage in mice. Left and right panel show preventive and curative 
effect of the protein respectively. Cont: GSH level in normal mice, GalN: GSH level in only GalN treated mice, Protein + GalN: 
GSH level in which the protein was given prior to GalN administration, VitE + GalN: GSH level in which vitamin E was admin-
istered prior to GalN treatment, BSA + GalN: GSH level in which BSA was given before GalN administration. GalN + Protein: 
GSH level in which the protein was given after GalN administration, GalN + Vit E: GSH level in which vitamin E was adminis-
tered post to GalN treatment and Recovery: GSH level in mice which were treated with GalN for 3 days and kept next 4 days 
without any treatment. Each column represents mean ± SD, n = 6. "a" indicates the significant difference between the vehicle 
control and toxin treated groups, "b" indicates the significant difference between the toxin treated and protein treated groups 
and "c" indicates the significant difference between the toxin treated and vitamin E treated groups. (Pa < 0.01, Pb < 0.01, Pc < 
0.01).
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Effect of the protein on GSSG level in GalN induced kidney damage in mice Figure 9
Effect of the protein on GSSG level in GalN induced kidney damage in mice. Left and right panel show preventive and curative 
effect of the protein respectively. Cont: GSSG level in normal mice, GalN: GSSG level in only GalN treated mice, Protein + 
GalN: GSSG level in which the protein was given prior to GalN administration, VitE + GalN: GSSG level in which vitamin E was 
administered prior to GalN treatment, BSA + GalN: GSSG level in which BSA was given before GalN administration. GalN + 
Protein: GSSG level in which the protein was given after GalN administration, GalN + Vit E: GSSG level in which vitamin E was 
administered post to GalN treatment and Recovery: GSSG level in mice which were treated with GalN for 3 days and kept 
next 4 days without any treatment. Each column represents mean ± SD, n = 6. "a" indicates the significant difference between 
the vehicle control and toxin treated groups, "b" indicates the significant difference between the toxin treated and protein 
treated groups and "c" indicates the significant difference between the toxin treated and vitamin E treated groups. (Pa < 0.01, Pb 
< 0.01, Pc < 0.01).
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Effect of the protein on levels of total thiols in GalN induced kidney damage in mice Figure 10
Effect of the protein on levels of total thiols in GalN induced kidney damage in mice. Left and right panel show preventive and 
curative effect of the protein respectively. Cont: total thiol level in normal mice, GalN: total thiol level in only GalN treated 
mice, Protein + GalN: total thiol level in which the protein was given prior to GalN administration, VitE + GalN: total thiol 
level in which vitamin E was administered prior to GalN treatment, BSA + GalN: total thiol level in which BSA was given before 
GalN administration. GalN + Protein: total thiol level in which the protein was given after GalN administration, GalN + Vit E: 
total thiol level in which vitamin E was administered post to GalN treatment and Recovery: total thiol level in mice which were 
treated with GalN for 3 days and kept next 4 days without any treatment. Each column represents mean ± SD, n = 6. "a" indi-
cates the significant difference between the vehicle control and toxin treated groups, "b" indicates the significant difference 
between the toxin treated and protein treated groups and "c" indicates the significant difference between the toxin treated and 
vitamin E treated groups. (Pa < 0.01, Pb < 0.01, Pc < 0.01).
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as SOD, CAT, GR and GST. GalN intoxication also
reduced the level of total thiol and GSH followed by the
increase in GSSG level. The renal dysfunction due to GalN
treatment was also manifested by the increase in serum
creatinine and UN levels as compared to the normal
group of mice. Protein treatment at a dose of 2 mg/kg
body weight for 4 days both prior and post to the toxin
administration attenuated the increased creatinine and
UN levels compared to the toxin control. Administration
of the protein restored the activities of intracellular anti-
oxidant enzymes SOD, CAT, GR and GST. The decreased
level of ROS scavengers like GSH and total thiols were also
enhanced by the protein treatment both prior and post to
the GalN intoxication. The content of total thiols includes
the protein-bound thiols as well as nonprotein-bound
thiols. It has been reported that the former usually con-
tribute more (a few fold higher than the later) to the total
thiols contents [54]. The protein also ameliorated the
enhanced level of TBARS as well as the level of GSSG com-
pared to the toxin control.
As reported from the earlier studies of our laboratory, the
protein could scavenge DPPH radicals as well as restore
the activities of different antioxidant enzymes and attenu-
ate various toxin-induced enhancement of lipid peroxida-
tion [31-34]. The detail mechanism of action of this
protein necessary for the protective action against hepatic
and renal damages is not yet fully known. As it possesses
hepatoprotective activity, it appears that the amelioration
of renal damage may not be its direct action to the kidney.
GalN induced renal failure appears at the end stage of liver
cirrhosis; so protecting the liver from that severe damage
it indirectly possesses protective role against GalN-
induced disorders in the kidney.
Although a number of very recent reports revealed that
protein molecules from various plant sources possess
antioxidant and hepatoprotective activities like the pro-
tein of our interest [55-57], similarities among their struc-
tural features could not be related at this stage because of
the lack of knowledge on their structures. These reports
also lack the knowledge of the exact mechanism of actions
of those protein molecules; only some biochemical prop-
erties are known and that could be compared to the pro-
tein of our interest.
Conclusion
In conclusion we would like to mention that GalN admin-
istration caused oxidative insult in the kidney. Protein
treatment both prior and post to the toxin administration
normalize that stress in the organ. As GalN induced renal
failure seems to occur at the end stage of liver cirrhosis, the
protective role of the protein against GalN induced renal
damages is likely to be an indirect effect probably comes
to play via the protection of hepatic disorders. Further
works are however needed to define the exact mechanisms
by which the protein exhibits this protective action and
are currently in progress.
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